Clinical Cancer Genomics conference, March 20-21 2025, Amsterdam

We are pleased to announce that registration for this novel exciting meeting focused on cancer whole genome and transcriptome sequencing in a clinical setting, is now open. Please visit www.ccg2025.eu for more information, abstract submission or registration of your participation!
An increasing number of European countries are adapting clinical cancer (gen)omics programs including whole genome and transcriptome sequencing (WGTS) to enable cancer precision medicine and support research and a learning health care system for improving future cancer care.
This meeting will be the first of an annual recurring series and aims to bring together researchers and medical specialists involved in these programs or interested in genomics-based and data-driven cancer care and/or research. The current state-of-the-art implementations in routine care, research highlights, clinical impact and future developments will be presented and discussed.
National programs in Europe supporting translation of genomics approaches from the clinic to research and back will be central to this meeting. The first meeting will take place on Thursday March 20 and Friday 21, 2025 in Amsterdam, the Netherlands, and is initiated as part of the 10th anniversary of Hartwig Medical Foundation. The meeting will be organised together with Genomics England, DKFZ German Cancer Research Center MASTER/NCT, Genomic Medicine Sweden, Plan France Médecine Génomique 2025 , and Danish National Genome Center.
All news
Also read
DataNexus connects clinical and genomic data
DataNexus is a project initiated by the Netherlands Cancer Institute–Antoni van Leeuwenhoek (NKI-AvL) to improve data availability by integrating clinical …
Collaboration between Hartwig and CKB makes both parties stronger
Hartwig Medical Foundation has worked with The Jackson Laboratory (JAX) Clinical Knowledgebase (CKB) team since 2020, to the benefit of …
Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients
Genetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, clinical …
It is important to unravel the DNA in rare types of cancer; 21% of patients with cancer have a rare form.